(Q38677670)

5 September 2017

1 reference

title

Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors (English)

1 reference

5 September 2017

Waeber B

1

1 reference

5 September 2017

Juillerat-Jeanneret L

2

1 reference

5 September 2017

Aubert JF

3

1 reference

5 September 2017

Schapira M

4

1 reference

5 September 2017

Nussberger J

5

1 reference

5 September 2017

Brunner HR

6

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

British Journal of Clinical Pharmacology

5 September 2017

1 reference

5 September 2017

27 Suppl 2

1 reference

5 September 2017

175S-180S

1 reference

Activation of membrane-bound kallikrein and renin in the kidney

5 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Hypertensive effect of a bradykinin antagonist in normotensive rats

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Effect of enalapril on the skin response to bradykinin in man.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

The cellular physiology of glandular kallikrein

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

The renal kallikrein-kinin system

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

The kallikrein-kinin system and the kidney

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

The renin-angiotensin system (first of two parts).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

The renal kallikrein-kinin system

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Angiotensin I converting enzyme

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Competitive antagonists of bradykinin

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

A pre-albumin activator of prekallikrein

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379745

An improved spectrophotometric assay for human plasma carboxypeptidase N1

31 August 2018

1 reference

12 December 2020

Release of a Prostaglandin E-Like Substance from Canine Kidney by Bradykinin

1 reference

12 December 2020

Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids

1 reference

12 December 2020

Hormonal responses to long-term converting enzyme inhibition in hypertensive patients

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels

1 reference

12 December 2020

Captopril, Aldosterone and Urinary Kallikrein in Primary Hypertension

1 reference

12 December 2020

Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N

1 reference

12 December 2020

Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist

1 reference

12 December 2020

The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system

1 reference

12 December 2020

Influence of endogenous bradykinin on acute blood pressure response to vasopressors in normotensive rats assessed with a bradykinin antagonist

1 reference

12 December 2020

Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction

1 reference

12 December 2020

Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension

1 reference

12 December 2020

Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism

1 reference

12 December 2020

10.1111/J.1365-2125.1989.TB03479.X

Identifiers

DOI

1 reference

5 September 2017

1 reference

5 September 2017

PubMed publication ID

2669913

1 reference